Serum PCSK9 levels in infants with deviant birth weight: a biomarker of the lipoprotein metabolism.

Antonios VlahosDimitrios RallisAlexandra LianouMaria BaltogianniNiki DermitzakiEleni MaragoudakiEleni PapastergiouChristos TzallasSophia TsabouriAlexandros MakisEkaterini SiomouHaralambos MilionisVasileios Giapros

Published in: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2023)

Serum PCSK9 levels were significantly associated with total and LDL cholesterol. PCSK9 levels were higher in preterm and small for gestation infants, suggesting that PCSK9 might be a promising biomarker for evaluating infants with increased later cardiovascular risk.

Keyphrases

low density lipoprotein
gestational age
birth weight
weight gain
preterm birth
body mass index
low birth weight